| 1 | Nephroblastoma | 47.9% |
| 2 | Renal Cell Carcinoma | 46.5% |
| 3 | Papillary Renal Cell Carcinoma | 46.5% |
| 4 | Bladder Neoplasm | 30.5% |
| 5 | Ureteral Neoplasms | 30.5% |
| 6 | Urethral Neoplasms | 30.5% |
| 7 | Denys-Drash Syndrome | 29.1% |
| 8 | Anuria | 25.3% |
| 9 | Nephrolithiasis | 25.3% |
| 10 | Tuberculosis, Renal | 22.5% |
| 11 | Hydronephrosis | 20.6% |
| 12 | Hyperoxaluria | 20.6% |
| 13 | Kidney Cortex Necrosis | 20.6% |
| 14 | Kidney Papillary Necrosis | 20.6% |
| 15 | Nephritis | 20.6% |
| 16 | Nephrosclerosis | 20.6% |
| 17 | Nephrosis | 20.6% |
| 18 | Perinephritis | 20.6% |
| 19 | Kidney Failure | 20.6% |
| 20 | Uremia | 20.6% |
| 21 | Oxalosis | 20.6% |
| 22 | Renal Insufficiency | 20.6% |
| 23 | Genital Neoplasms, Male | 18.9% |
| 24 | Genital Neoplasms, Female | 18.9% |
| 25 | Diabetes Insipidus | 18.5% |
| 26 | Hepatorenal Syndrome | 18.5% |
| 27 | Urinary Bladder Diseases | 18.4% |
| 28 | Ureteral Diseases | 18.4% |
| 29 | Urethral Diseases | 18.4% |
| 30 | Urination Disorders | 18.4% |
| 31 | Urolithiasis | 18.4% |
| 32 | Diabetic Nephropathy | 18.4% |
| 33 | Renal hypertension | 18.4% |
| 34 | Renal Artery Obstruction | 18.4% |
| 35 | Renal Artery Stenosis | 18.4% |
| 36 | Nephrocalcinosis | 18.3% |
| 37 | Multicystic Dysplastic Kidney | 17.5% |
| 38 | Ureterolithiasis | 17.5% |
| 39 | Kidney Calculi | 17.3% |
| 40 | Urogenital Abnormalities | 16.9% |
| 41 | Carcinosarcoma | 16.6% |
| 42 | Urinary tract infection | 16.5% |
| 43 | Pyelonephritis | 16.3% |
| 44 | Endometrial Stromal Sarcoma | 15.7% |
| 45 | Bladder Exstrophy | 15.5% |
| 46 | Epispadias | 15.5% |
| 47 | AIDS-Associated Nephropathy | 15% |
| 48 | Carcinoma 256, Walker | 15% |
| 49 | Composite Lymphoma | 14.6% |
| 50 | Bladder neck obstruction | 14.5% |
| 51 | Mesenchymoma | 14.1% |
| 52 | Hepatoblastoma | 14.1% |
| 53 | Mixed Tumor, Mullerian | 14.1% |
| 54 | Pyelocystitis | 13.9% |
| 55 | Thymoma | 13.7% |
| 56 | Glomerulonephritis | 13.7% |
| 57 | Nephritis, Interstitial | 13.7% |
| 58 | Lipoid nephrosis | 13.7% |
| 59 | Nephrotic Syndrome | 13.7% |
| 60 | Pyelitis | 13.7% |
| 61 | Pyonephrosis | 13.7% |
| 62 | Nephrogenic Diabetes Insipidus | 13.7% |
| 63 | Congenital Nephrogenic Diabetes Insipidus | 13.7% |
| 64 | Acute kidney injury | 13.7% |
| 65 | Uterine Neoplasms | 13.4% |
| 66 | Vaginal Neoplasms | 13.4% |
| 67 | Vulvar Neoplasms | 13.4% |
| 68 | Uterine Cancer | 13.4% |
| 69 | Ureteral Calculi | 13.3% |
| 70 | Glycosuria, Renal | 12.9% |
| 71 | Neoplasms, Neuroepithelial | 12.7% |
| 72 | Gliomatosis cerebri | 12.7% |
| 73 | Renal Osteodystrophy | 12.6% |
| 74 | Renal rickets | 12.6% |
| 75 | Medulloblastoma | 12.5% |
| 76 | Urinary Bladder Fistula | 12.4% |
| 77 | Fallopian Tube Neoplasms | 12.3% |
| 78 | Azotemia | 12.3% |
| 79 | Penile Neoplasms | 12.2% |
| 80 | Prostatic Neoplasms | 12.2% |
| 81 | Hypertension, Renovascular | 12.1% |
| 82 | Testicular Neoplasms | 11.8% |
| 83 | Neuroectodermal Tumors | 11.8% |
| 84 | Pregnancy Complications, Neoplastic | 11.5% |
| 85 | melanoma | 11.3% |
| 86 | Meningioma | 11.2% |
| 87 | Polycystic Kidney Diseases | 11% |
| 88 | Renal Aminoacidurias | 10.9% |
| 89 | Fanconi Syndrome | 10.9% |
| 90 | Pseudohypoaldosteronism | 10.9% |
| 91 | Liddle Syndrome | 10.9% |
| 92 | Trophoblastic Neoplasms | 10.9% |
| 93 | Hemolytic-Uremic Syndrome | 10.9% |
| 94 | Cystitis | 10.9% |
| 95 | Ureteral obstruction | 10.9% |
| 96 | Ureterocele | 10.9% |
| 97 | Urethral Obstruction | 10.9% |
| 98 | Urethritis | 10.9% |
| 99 | Vesico-Ureteral Reflux | 10.9% |
| 100 | Urinary Retention | 10.9% |
| 101 | Melanoma, Experimental | 10.6% |
| 102 | leukemia | 10.5% |
| 103 | Neoplasms, Germ Cell and Embryonal | 10.5% |
| 104 | Neoplasms, Glandular and Epithelial | 10.5% |
| 105 | Germ Cell Cancer | 10.5% |
| 106 | Zellweger Syndrome | 10.4% |
| 107 | Infertility | 10.2% |
| 108 | Balkan Nephropathy | 10.2% |
| 109 | Focal glomerulosclerosis | 10.2% |
| 110 | Kidney Failure, Chronic | 10.2% |
| 111 | Hypospadias | 10.2% |
| 112 | Carcinoma, Endometrioid | 10.1% |
| 113 | Hemangiosarcoma | 10.1% |
| 114 | lymphangiosarcoma | 10.1% |
| 115 | Renal tubular acidosis | 9.9% |
| 116 | Carcinoma, Lobular | 9.8% |
| 117 | Multiple Endocrine Neoplasia | 9.8% |
| 118 | Adenoma, Acidophil | 9.8% |
| 119 | Ganglioneuroma | 9.8% |
| 120 | Glioma | 9.8% |
| 121 | Malignant Glioma | 9.8% |
| 122 | Bacteriuria | 9.7% |
| 123 | Glycosuria | 9.7% |
| 124 | Hematuria | 9.7% |
| 125 | Oliguria | 9.7% |
| 126 | Polyuria | 9.7% |
| 127 | Proteinuria | 9.7% |
| 128 | Pyuria | 9.7% |
| 129 | Urinary Calculi | 9.7% |
| 130 | Cystocele | 9.7% |
| 131 | Urinary Incontinence | 9.7% |
| 132 | ovarian neoplasm | 9.6% |
| 133 | Urologic Diseases | 9.4% |
| 134 | Glomerulonephritis, Membranoproliferative | 9.3% |
| 135 | Histiocytic Disorders, Malignant | 9.2% |
| 136 | Choriocarcinoma | 9.2% |
| 137 | Horseshoe Kidney | 9.1% |
| 138 | Abdominal Neoplasms | 9.1% |
| 139 | Head and Neck Neoplasms | 9.1% |
| 140 | Soft Tissue Neoplasms | 9.1% |
| 141 | Thoracic Neoplasms | 9.1% |
| 142 | Carcinoid Tumor | 9.1% |
| 143 | Endometrial Neoplasms | 9.1% |
| 144 | Neurilemmoma | 9.1% |
| 145 | Hutchinson's Melanotic Freckle | 9.1% |
| 146 | Melanoma, Amelanotic | 9.1% |
| 147 | Leukemia, Experimental | 9.1% |
| 148 | Leukemia, Plasma Cell | 9% |
| 149 | Acanthoma | 8.9% |
| 150 | Enuresis | 8.8% |
| 151 | Hamartoma | 8.8% |
| 152 | Neoplasms, Hormone-Dependent | 8.8% |
| 153 | Neoplasms, Multiple Primary | 8.8% |
| 154 | Paraneoplastic Syndromes | 8.8% |
| 155 | Precancerous Conditions | 8.8% |
| 156 | Neoplasms, Second Primary | 8.8% |
| 157 | Retinoblastoma | 8.8% |
| 158 | granulosa cell tumor | 8.7% |
| 159 | Carcinoma, Ovarian Epithelial | 8.7% |
| 160 | Carcinoma, Ehrlich Tumor | 8.6% |
| 161 | Dermoid Cyst | 8.6% |
| 162 | Carcinoma, Lewis Lung | 8.6% |
| 163 | Genital Diseases, Male | 8.6% |
| 164 | Basal cell carcinoma | 8.5% |
| 165 | Carcinoma, Papillary | 8.5% |
| 166 | Squamous cell carcinoma | 8.5% |
| 167 | Chondrosarcoma | 8.5% |
| 168 | Craniopharyngioma | 8.5% |
| 169 | Cystadenoma | 8.5% |
| 170 | leiomyosarcoma | 8.5% |
| 171 | liposarcoma | 8.5% |
| 172 | Mesothelioma | 8.5% |
| 173 | synovial sarcoma | 8.5% |
| 174 | Neuroectodermal Tumor, Melanotic | 8.5% |
| 175 | Angiomyolipoma | 8.5% |
| 176 | Clear Cell Sarcoma of Soft Tissue | 8.5% |
| 177 | Alveolar Soft Part Sarcoma | 8.5% |
| 178 | Neuroendocrine Tumors | 8.5% |
| 179 | Sarcoma, Myeloid | 8.5% |
| 180 | Carcinoma, Basal Cell | 8.5% |
| 181 | Sexually Transmitted Diseases | 8.4% |
| 182 | Hyperphosphaturia | 8.4% |
| 183 | Astrocytoma | 8.3% |
| 184 | Ependymoma | 8.3% |
| 185 | oligodendroglioma | 8.3% |
| 186 | Ganglioglioma | 8.3% |
| 187 | gliosarcoma | 8.3% |
| 188 | Anaplastic astrocytoma | 8.3% |
| 189 | Anaplastic Oligodendroglioma | 8.3% |
| 190 | Anti-Glomerular Basement Membrane Disease | 8.3% |
| 191 | Hermaphroditism | 8.3% |
| 192 | Disorders of Sex Development | 8.3% |
| 193 | Leukemia, Radiation-Induced | 8.2% |
| 194 | Lupus Nephritis | 8.2% |
| 195 | Prostatic Neoplasms, Castration-Resistant | 8.2% |
| 196 | Lymphoma | 8.2% |
| 197 | Genital Herpes | 8.2% |
| 198 | Polycystic Kidney, Autosomal Dominant | 8.2% |
| 199 | Digestive System Neoplasms | 8.2% |
| 200 | Endocrine Gland Neoplasms | 8.2% |
| 201 | Eye Neoplasms | 8.2% |
| 202 | Nervous System Neoplasms | 8.2% |
| 203 | Cystinuria | 8.2% |
| 204 | Atypical Hemolytic Uremic Syndrome | 8.1% |
| 205 | Pregnancy Complications | 8.1% |
| 206 | Paraneoplastic Encephalomyelitis | 8.1% |
| 207 | Bone neoplasms | 8% |
| 208 | Skin Neoplasms | 8% |
| 209 | Hematologic Neoplasms | 8% |
| 210 | Malignant Carcinoid Syndrome | 8% |
| 211 | Mammary Neoplasms, Experimental | 8% |
| 212 | Splenic Neoplasms | 8% |
| 213 | Cyst | 7.8% |
| 214 | Neoplastic Processes | 7.8% |
| 215 | Neoplastic Syndromes, Hereditary | 7.8% |
| 216 | Carcinoma, Pancreatic Ductal | 7.7% |
| 217 | Neoplasms, Experimental | 7.7% |
| 218 | Acoustic Neuroma | 7.7% |
| 219 | Cystadenocarcinoma | 7.6% |
| 220 | Fibrosarcoma | 7.6% |
| 221 | Osteosarcoma | 7.6% |
| 222 | Mucoepidermoid Carcinoma | 7.6% |
| 223 | Glioblastoma | 7.6% |
| 224 | Neuroblastoma | 7.6% |
| 225 | Glioblastoma Multiforme | 7.6% |
| 226 | Parathyroid Neoplasms | 7.6% |
| 227 | Peritoneal Neoplasms | 7.6% |
| 228 | Thyroid Neoplasm | 7.6% |
| 229 | Thyroid carcinoma | 7.6% |
| 230 | Sarcoma, Experimental | 7.6% |
| 231 | Leydig Cell Tumor | 7.5% |
| 232 | Ganglioneuroblastoma | 7.3% |
| 233 | Urethral Stenosis | 7.2% |
| 234 | Urethral stricture | 7.2% |
| 235 | Adenofibroma | 7.2% |
| 236 | Fibroadenoma | 7.2% |
| 237 | Malignant Fibrous Histiocytoma | 7.2% |
| 238 | Neurofibrosarcoma | 7.1% |
| 239 | Tuberous Sclerosis | 7% |
| 240 | Pancreatic Neoplasm | 7% |
| 241 | Endometriosis | 6.9% |
| 242 | Uterine Diseases | 6.9% |
| 243 | Vaginal Diseases | 6.9% |
| 244 | Vulvar Diseases | 6.9% |
| 245 | Endometrioma | 6.9% |
| 246 | Leukemia L1210 | 6.9% |
| 247 | Leukemia P388 | 6.9% |
| 248 | Neoplasms, Radiation-Induced | 6.9% |
| 249 | Bowen's Disease | 6.8% |
| 250 | Paraganglioma | 6.8% |
| 251 | Rhabdomyosarcoma | 6.8% |
| 252 | Giant Cell Tumor of Bone | 6.8% |
| 253 | Carcinoid Heart Disease | 6.8% |
| 254 | Lymphangioleiomyomatosis | 6.8% |
| 255 | Basal Cell Nevus Syndrome | 6.7% |
| 256 | Optic Nerve Glioma | 6.7% |
| 257 | Adenoma | 6.7% |
| 258 | Ameloblastoma | 6.7% |
| 259 | Angiokeratoma | 6.7% |
| 260 | Carcinoma | 6.7% |
| 261 | Chordoma | 6.7% |
| 262 | Hemangioma | 6.7% |
| 263 | hemangiopericytoma | 6.7% |
| 264 | Lymphangioma | 6.7% |
| 265 | Nevus | 6.7% |
| 266 | Teratoma | 6.7% |
| 267 | Germinoma | 6.7% |
| 268 | Teratocarcinoma | 6.7% |
| 269 | Angiofibroma | 6.7% |
| 270 | Sarcoma | 6.7% |
| 271 | Epithelioma | 6.7% |
| 272 | Albuminuria | 6.4% |
| 273 | Hemoglobinuria | 6.4% |
| 274 | Urge Incontinence | 6.4% |
| 275 | Dermatofibrosarcoma | 6.4% |
| 276 | Dermatofibrosarcoma Protuberans | 6.4% |
| 277 | Vesicovaginal Fistula | 6.4% |
| 278 | Vipoma | 6.4% |
| 279 | Tracheal Neoplasms | 6.3% |
| 280 | Lymphomatoid Granulomatosis | 6.1% |
| 281 | Multiple Endocrine Neoplasia Type 1 | 6.1% |
| 282 | Sarcoma 180 | 6% |
| 283 | Endometritis | 6% |
| 284 | Urologic Neoplasms | 6% |
| 285 | Pheochromocytoma | 6% |
| 286 | Alveolar rhabdomyosarcoma | 6% |
| 287 | Corpus Luteum Cyst | 6% |
| 288 | Ovarian Cysts | 6% |
| 289 | Plasmacytoma | 5.9% |
| 290 | Malignant histiocytosis | 5.9% |
| 291 | Histiocytic sarcoma | 5.9% |
| 292 | Hepatocellular Adenoma | 5.8% |
| 293 | Diurnal Enuresis | 5.8% |
| 294 | Uterine Inversion | 5.7% |
| 295 | Esophageal Neoplasms | 5.6% |
| 296 | Dyspareunia | 5.4% |
| 297 | Liver Neoplasms, Experimental | 5.3% |
| 298 | Hydatidiform Mole | 5.3% |
| 299 | Retroperitoneal Neoplasms | 5.3% |
| 300 | Kidney Neoplasm | 5.3% |
| 301 | Prolactinoma | 5.3% |
| 302 | Growth Hormone-Secreting Pituitary Adenoma | 5.3% |
| 303 | Cryptorchidism | 5.3% |
| 304 | insulinoma | 5.2% |
| 305 | Hodgkin Disease | 5.2% |
| 306 | Lymphoma, Non-Hodgkin | 5.2% |
| 307 | Kidney Diseases | 5.1% |
| 308 | Uterine Rupture | 5.1% |
| 309 | Adenomatous Polyposis Coli | 5.1% |
| 310 | Gastrinoma | 4.9% |
| 311 | Glucagonoma | 4.9% |
| 312 | Erythroplasia | 4.9% |
| 313 | Follicular cyst | 4.9% |
| 314 | Mucocele | 4.9% |
| 315 | Pilonidal Cyst | 4.9% |
| 316 | Thyroglossal Cyst | 4.9% |
| 317 | Synovial Cyst | 4.9% |
| 318 | Aberrant Crypt Foci | 4.9% |
| 319 | Gonadal Dysgenesis | 4.9% |
| 320 | Thyroid Nodule | 4.9% |
| 321 | Adrenogenital Syndrome | 4.9% |
| 322 | Ovotesticular Disorders of Sex Development | 4.9% |
| 323 | Adenocarcinoma | 4.8% |
| 324 | Carcinoma in Situ | 4.8% |
| 325 | Carcinoma, Transitional Cell | 4.8% |
| 326 | Phyllodes Tumor | 4.8% |
| 327 | Dysgerminoma | 4.8% |
| 328 | Hemangioendothelioma | 4.8% |
| 329 | Lipoma | 4.8% |
| 330 | Myoma | 4.8% |
| 331 | Myxoma | 4.8% |
| 332 | Neuroma | 4.8% |
| 333 | Papilloma | 4.8% |
| 334 | Pseudomyxoma Peritonei | 4.8% |
| 335 | Seminoma | 4.8% |
| 336 | Papillomatosis | 4.8% |
| 337 | Angiolipoma | 4.8% |
| 338 | Myelolipoma | 4.8% |
| 339 | Neoplasms, Bone Tissue | 4.8% |
| 340 | Neoplasms, Fibrous Tissue | 4.8% |
| 341 | Smooth Muscle Tumor | 4.8% |
| 342 | Adenomatosis, Pulmonary | 4.8% |
| 343 | Adenomatous Polyps | 4.8% |
| 344 | Carcinoma, Large Cell | 4.8% |
| 345 | Carcinoma, Small Cell | 4.8% |
| 346 | Desmoplastic Small Round Cell Tumor | 4.8% |
| 347 | Chondroma | 4.8% |
| 348 | Enchondroma | 4.8% |
| 349 | Salpingitis | 4.8% |
| 350 | Vulvovaginitis | 4.8% |
| 351 | Primary amyloidosis | 4.7% |
| 352 | Mouth Neoplasms | 4.7% |
| 353 | Central Nervous System Neoplasms | 4.7% |
| 354 | Vascular Neoplasms | 4.7% |
| 355 | Thymus Neoplasms | 4.7% |
| 356 | Epididymitis | 4.7% |
| 357 | Penile Diseases | 4.7% |
| 358 | Prostatic Diseases | 4.7% |
| 359 | Spermatic Cord Torsion | 4.7% |
| 360 | Hemospermia | 4.7% |
| 361 | Testicular Hydrocele | 4.7% |
| 362 | Breast Neoplasms, Male | 4.6% |
| 363 | Triple Negative Breast Neoplasms | 4.6% |
| 364 | Hyperandrogenism | 4.6% |
| 365 | Leukoplakia, Oral | 4.6% |
| 366 | Paraneoplastic Cerebellar Degeneration | 4.5% |
| 367 | Familial Hypophosphatemic Rickets | 4.5% |
| 368 | Leukoplakia | 4.3% |
| 369 | Lymphocele | 4.3% |
| 370 | Pancreatic Cyst | 4.3% |
| 371 | Barrett Esophagus | 4.3% |
| 372 | Breast Cyst | 4.3% |
| 373 | Actinic keratosis | 4.3% |
| 374 | Mediastinal Cyst | 4.3% |
| 375 | Neoplasm Invasiveness | 4.3% |
| 376 | Neoplasm Metastasis | 4.3% |
| 377 | Neoplasm Recurrence, Local | 4.3% |
| 378 | Parovarian Cyst | 4.3% |
| 379 | Pericardial Cyst | 4.3% |
| 380 | Thymic Cyst | 4.3% |
| 381 | Carcinogenesis | 4.3% |
| 382 | Myxoid cyst | 4.3% |
| 383 | Metastasis | 4.3% |
| 384 | Oophoritis | 4.3% |
| 385 | Chorioamnionitis | 4.3% |
| 386 | Leukemia, Myelomonocytic, Chronic | 4.2% |
| 387 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.2% |
| 388 | Adrenal Gland Neoplasms | 4.2% |
| 389 | Gastrointestinal Neoplasms | 4.2% |
| 390 | Liver neoplasms | 4.2% |
| 391 | Uveal Neoplasms | 4.2% |
| 392 | Polyhydramnios | 4.2% |
| 393 | Obstetric Labor Complications | 4.2% |
| 394 | Ectopic Pregnancy | 4.2% |
| 395 | Pregnancy, Prolonged | 4.2% |
| 396 | Puerperal Disorders | 4.2% |
| 397 | Oligohydramnios | 4.2% |
| 398 | Prenatal Injuries | 4.2% |
| 399 | Sebaceous Gland Neoplasms | 4.2% |
| 400 | Spinal Neoplasms | 4.2% |
| 401 | Bone Marrow Neoplasms | 4.2% |
| 402 | Endometrial Hyperplasia | 4.1% |
| 403 | Pyometra | 4.1% |
| 404 | Vaginitis | 4.1% |
| 405 | Vulvitis | 4.1% |
| 406 | Vaginal Discharge | 4.1% |
| 407 | Vulvodynia | 4.1% |
| 408 | Testicular Diseases | 4.1% |
| 409 | Varicocele | 4.1% |
| 410 | Limbic Encephalitis | 4.1% |
| 411 | Spermatocele | 4.1% |
| 412 | Adrenocortical carcinoma | 4.1% |
| 413 | Abruptio Placentae | 4.1% |
| 414 | Placenta Accreta | 4.1% |
| 415 | Mesoblastic Nephroma | 4% |
| 416 | Polycystic Ovary Syndrome | 3.9% |
| 417 | Waldenstrom Macroglobulinemia | 3.9% |
| 418 | Multiple Myeloma | 3.9% |
| 419 | Adenoid Cystic Carcinoma | 3.9% |
| 420 | fibroma | 3.9% |
| 421 | Fibromatosis | 3.9% |
| 422 | Osteoblastoma | 3.9% |
| 423 | Osteoma | 3.9% |
| 424 | Rhabdomyoma | 3.9% |
| 425 | Chondromatosis | 3.9% |
| 426 | Adenocarcinoma, Clear Cell | 3.9% |
| 427 | Cholangiocarcinoma | 3.9% |
| 428 | Cervical Intraepithelial Neoplasia | 3.9% |
| 429 | Hemangioblastoma | 3.9% |
| 430 | Lymphoma, Extranodal NK-T-Cell | 3.9% |
| 431 | Nose Neoplasms | 3.8% |
| 432 | Lambert-Eaton Myasthenic Syndrome | 3.8% |
| 433 | Mastocytosis | 3.8% |
| 434 | Sturge-Weber Syndrome | 3.8% |
| 435 | Gastrointestinal Stromal Tumors | 3.8% |
| 436 | Fetal Diseases | 3.8% |
| 437 | Pregnancy Complications, Cardiovascular | 3.8% |
| 438 | Hemangioma, Cavernous | 3.8% |
| 439 | Leukemia, T-Cell | 3.8% |
| 440 | Leukemia, B-Cell | 3.8% |
| 441 | neurofibroma | 3.7% |
| 442 | Lymphoma, Follicular | 3.7% |
| 443 | T-Cell Lymphoma | 3.7% |
| 444 | Mantle cell lymphoma | 3.7% |
| 445 | Pregnancy Complications, Hematologic | 3.7% |
| 446 | Pregnancy Complications, Infectious | 3.7% |
| 447 | Nasopharyngeal carcinoma | 3.7% |
| 448 | Fetal Death | 3.7% |
| 449 | Perinatal death | 3.7% |
| 450 | Ovarian Diseases | 3.7% |
| 451 | Morning Sickness | 3.7% |
| 452 | Adnexitis | 3.6% |
| 453 | Pruritus Vulvae | 3.6% |
| 454 | Uterine hemorrhage | 3.6% |
| 455 | Vaginal Fistula | 3.6% |
| 456 | Pelvic Inflammatory Disease | 3.6% |
| 457 | Uterine Prolapse | 3.6% |
| 458 | Vaginal Prolapse | 3.6% |
| 459 | Puerperal Infection | 3.6% |
| 460 | Uterine Cervical Incompetence | 3.6% |
| 461 | Postpartum Hemorrhage | 3.6% |
| 462 | Pituitary Adenoma | 3.6% |
| 463 | Pituitary Neoplasms | 3.6% |
| 464 | Opsoclonus-Myoclonus Syndrome | 3.5% |
| 465 | Palatal Neoplasms | 3.5% |
| 466 | Choledochal Cyst | 3.5% |
| 467 | Fibromatosis, Aggressive | 3.4% |
| 468 | Fibromatosis, Abdominal | 3.4% |
| 469 | Klatskin Tumor | 3.4% |
| 470 | Mastocytoma | 3.4% |
| 471 | Peutz-Jeghers Syndrome | 3.4% |
| 472 | Mastocytosis, Systemic | 3.4% |
| 473 | Leukemia, Myeloid, Chronic-Phase | 3.4% |
| 474 | Turner Syndrome | 3.4% |
| 475 | Gestational Diabetes | 3.3% |
| 476 | Myelitis, Transverse | 3.3% |
| 477 | Candidiasis, Vulvovaginal | 3.2% |
| 478 | Meningeal Neoplasms | 3% |
| 479 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 480 | Leukemia, Large Granular Lymphocytic | 3% |
| 481 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 482 | Lymphoma, T-Cell, Cutaneous | 3% |
| 483 | Lymphoma, AIDS-Related | 3% |
| 484 | Enteropathy-Associated T-Cell Lymphoma | 3% |
| 485 | Primary Effusion Lymphoma | 3% |
| 486 | Chlamydia Infections | 2.9% |
| 487 | Gonorrhea | 2.9% |
| 488 | Balanitis | 2.8% |
| 489 | Benign prostatic hypertrophy | 2.8% |
| 490 | Phimosis | 2.8% |
| 491 | Priapism | 2.8% |
| 492 | prostatitis | 2.8% |
| 493 | Prostatic Adenoma | 2.8% |
| 494 | Benign Prostatic Hyperplasia | 2.8% |
| 495 | Prostatic Hypertrophy | 2.8% |
| 496 | Prostatic Hyperplasia | 2.8% |
| 497 | Uterine Cervicitis | 2.8% |
| 498 | Leukorrhea | 2.8% |
| 499 | Parametritis | 2.8% |
| 500 | Ear Neoplasms | 2.7% |
| 501 | Eyelid Neoplasms | 2.7% |
| 502 | Lung Neoplasms | 2.7% |
| 503 | Pleural Neoplasms | 2.7% |
| 504 | Dupuytren Contracture | 2.7% |
| 505 | Kallmann Syndrome | 2.7% |
| 506 | Brain Neoplasms | 2.7% |
| 507 | Salivary Gland Neoplasms | 2.7% |
| 508 | Spinal Cord Neoplasms | 2.7% |
| 509 | Tongue Neoplasms | 2.7% |
| 510 | Syphilis | 2.7% |
| 511 | Urticaria Pigmentosa | 2.7% |
| 512 | Mycosis Fungoides | 2.7% |
| 513 | Lymphomatoid Papulosis | 2.7% |
| 514 | Plasmablastic lymphoma | 2.7% |
| 515 | Pancreatic Pseudocyst | 2.6% |
| 516 | Lymphatic Metastasis | 2.6% |
| 517 | Neoplasms, Unknown Primary | 2.6% |
| 518 | Leukemic Infiltration | 2.6% |
| 519 | Neoplasm Micrometastasis | 2.6% |
| 520 | Pharyngeal Neoplasms | 2.5% |
| 521 | Burkitt Lymphoma | 2.5% |
| 522 | Xeroderma Pigmentosum | 2.5% |
| 523 | Klinefelter Syndrome | 2.5% |
| 524 | Central Nervous System Cysts | 2.5% |
| 525 | Premature Ejaculation | 2.5% |
| 526 | Erectile dysfunction | 2.5% |
| 527 | Bile Duct Neoplasms | 2.4% |
| 528 | gallbladder neoplasm | 2.4% |
| 529 | Intestinal Neoplasms | 2.4% |
| 530 | Stomach Neoplasms | 2.4% |
| 531 | Bacterial Vaginosis | 2.4% |
| 532 | Orchitis | 2.4% |
| 533 | Trichomonas Vaginitis | 2.4% |
| 534 | Uterine Perforation | 2.4% |
| 535 | Ovarian Hyperstimulation Syndrome | 2.4% |
| 536 | Polycythemia Vera | 2.4% |
| 537 | Metrorrhagia | 2.4% |
| 538 | Abortion, Habitual | 2.3% |
| 539 | Dystocia | 2.3% |
| 540 | Eclampsia | 2.3% |
| 541 | Fetal Membranes, Premature Rupture | 2.3% |
| 542 | Placental Insufficiency | 2.3% |
| 543 | Pre-Eclampsia | 2.3% |
| 544 | Prenatal Exposure Delayed Effects | 2.3% |
| 545 | HELLP Syndrome | 2.3% |
| 546 | Placenta, Retained | 2.3% |
| 547 | Laryngeal neoplasm | 2.3% |
| 548 | Meningeal Carcinomatosis | 2.2% |
| 549 | Sezary Syndrome | 2.2% |
| 550 | Lymphogranuloma Venereum | 2.2% |
| 551 | Anovulation | 2.2% |
| 552 | Menorrhagia | 2.2% |
| 553 | Premature Menopause | 2.1% |
| 554 | Abortion, Veterinary | 2.1% |
| 555 | Pregnancy Complications, Parasitic | 2.1% |
| 556 | Lactation Disorder | 2% |
| 557 | Mastitis | 2% |
| 558 | Depression, Postpartum | 2% |
| 559 | Embryo Loss | 2% |
| 560 | Fetal Resorption | 2% |
| 561 | Hyperemesis Gravidarum | 2% |
| 562 | Bronchial Neoplasms | 2% |
| 563 | Multiple Pulmonary Nodules | 2% |
| 564 | Supratentorial Neoplasms | 2% |
| 565 | Azoospermia | 1.8% |
| 566 | Oligospermia | 1.8% |
| 567 | Impotence, Vasculogenic | 1.8% |
| 568 | Asthenozoospermia | 1.8% |
| 569 | Teratozoospermia | 1.8% |
| 570 | Aspermia | 1.8% |
| 571 | Fetal Growth Retardation | 1.8% |
| 572 | Embolism, Amniotic Fluid | 1.8% |
| 573 | Fetal Hypoxia | 1.8% |
| 574 | Fetal Alcohol Spectrum Disorders | 1.8% |
| 575 | Breech Presentation | 1.8% |
| 576 | Stillbirth | 1.8% |
| 577 | Hypopharyngeal Neoplasms | 1.8% |
| 578 | Pleural Effusion, Malignant | 1.8% |
| 579 | Hypopharyngeal Cancer | 1.8% |
| 580 | Parotid Neoplasms | 1.8% |
| 581 | Nelson Syndrome | 1.8% |
| 582 | Zollinger-Ellison syndrome | 1.6% |
| 583 | Cell Transformation, Viral | 1.6% |
| 584 | Cecal Neoplasms | 1.6% |
| 585 | Duodenal Neoplasms | 1.6% |
| 586 | Brain Stem Neoplasms | 1.6% |
| 587 | Meconium Aspiration Syndrome | 1.5% |
| 588 | Nasopharyngeal Neoplasms | 1.5% |
| 589 | Colorectal Neoplasms | 1.5% |
| 590 | Tonsillar Neoplasms | 1.4% |
| 591 | Cerebellar Neoplasms | 1.4% |
| 592 | Choroid Plexus Papilloma | 1.4% |
| 593 | Paranasal Sinus Neoplasms | 1.4% |
| 594 | Premature Birth | 1.4% |
| 595 | Appendiceal Neoplasms | 1.3% |
| 596 | Colonic Neoplasms | 1.3% |
| 597 | Rectal Neoplasms | 1.3% |
| 598 | Galactorrhea | 1.2% |
| 599 | Maxillary Sinus Neoplasms | 1.1% |
| 600 | Anus Neoplasms | 1.1% |
| 601 | Sigmoid Neoplasms | 1.1% |
| 602 | Radicular Cyst | 0.9% |
| 603 | Hydrops Fetalis | 0.8% |